Cabozantinib for Late Stage Kidney Cancer
Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.
GRACEcast 259 Kidney
Author: cancergrace
Added: 08/13/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Kidney Cancer | Thyroid | Thyroid Cancer | Urology & Nephrology